Feifei Liu

Feifei Liu began their work experience in 2013 as a Production Planner/Coordinator at Nature's Care Manufacture Pty Limited, where they scheduled daily production plans and ensured compliance with GMP requirements. From 2015 to 2018, they worked as a Quality Assurance Engineer at Shandong Luye Pharmaceutical Co., Ltd., conducting quality assurance activities and implementing risk assessment management procedures. In 2018, they became a Quality Assurance Supervisor at Shandong Luye Pharmacuetical Co., Ltd., where they supervised QA engineers and participated in GMP/cGMP inspections. In 2019, Feifei joined The University of Queensland as a Research Assistant and PHD Candidate, specializing in the development of precision theranostic nanomedicine for immuno cancer therapy. Feifei'sresponsibilities included chemical synthesis, nanoparticle delivery system design, and analytical characterization methods. Most recently, they have joined AdvanCell Isotopes Pty Ltd as a Preclinical Scientist in 2023.

Feifei Liu has an extensive education history. Feifei obtained a Doctor of Philosophy (PhD) degree in Nanotechnology at The University of Queensland from 2019 to 2023. Feifei'sresearch focused on Immuno-boosting drug delivery and Theranostics. Prior to this, Feifei completed a Master's degree in Chemical and Biomolecular Engineering at The University of Sydney from 2010 to 2011. Feifei'sundergraduate education was at Central South University, where they earned a Bachelor's degree in Pharmacuetical Engineering from 2005 to 2009.

In addition to their academic qualifications, Feifei Liu has also pursued further certifications in their field. Feifei obtained a GCP (Good Clinical Practice) certificate from the Western Australian Health Translation Network in March 2022. Furthermore, they attended a cGMP & FDA inspection conference organized by the FDA in July 2015. These certifications highlight their dedication to professional development and staying up-to-date with industry standards.